HIV Malignancy Specimens for Research at No Charge
On behalf of Toby T. Hecht, Ph.D. Associate Director, Translational Research Program, DCTD, NCI and Robert Yarchoan, M.D., Director, Office of HIV and AIDS Malignancy, NCI To the HIV Malignancy …
From the National Cancer Institute https://cancercontrol.cancer.gov/brp/events/pre-application-webinar-the-confluence-of-cancer-stigma-and-hiv-stigma-in-hiv-positive-individuals-diagnosed-with-cancer?cid=eb_govdel Pre-Application Webinar: The Confluence of Cancer Stigma and HIV Stigma in HIV-Positive Individuals Diagnosed with Cancer Date: Wednesday, September 25, 2024, 1:00 p.m.–2:00 p.m. ETRegistration …
This meeting is presented by the Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services will take place October 24, 25, at …
Congratulations to National Cancer Institute (NCI) Center for Global Health (CGH) Director, Satish Gopal, recipient of American Society of Clinical Oncology (ASCO) 2024 Humanitarian Award, recognizing his outstanding leadership in …
It’s National Cancer Prevention and Early Detection Month!(https://www.whitehouse.gov/briefing-room/presidential-actions/2024/03/29/a-proclamation-on-cancer-control-month-2024/). Human papillomavirus (HPV) is the most the common sexually transmitted infection (STI) in the United States (per CDC’s STD Facts on HPV), and is …
Drs. Elaine Jaffe, Louis Staudt and Robert Yarchoan at The National Institutes of Health recipients of Departmental Awards from the U.S. Department of Health and Human Services (HHS) for their groundbreaking research leading to …
The ACSR extends a warm welcome to Dr. Kim Rathmell, NCI Director. Dr. W. Kimryn Rathmell began her work as 17th director of the National Cancer Institute on December 18th …
The National Cancer Institute’s Division of Cancer Epidemiology and Genetics released a summary of 3 studies that have the potential for informing recommendations for anal cancer screening, the importance of …
Learn more about ComboMATCH: the new clinical trial initiative to evaluate combinations of treatments that block both the drivers of tumor growth and the mechanisms of resistance. The primary goal for ComboMATCH …
The ACSR congratulates Dr. Monica Bertagnolli as she takes the helm as the 17th NIH Director! She is the first surgeon and the second woman to hold the position. Nominated …